Gliford 5 – Glibenclamide IP 5 Mg
Glibenclamide IP 5 Mg
Exporter, Distributor Drop shipper to Russia, Brazil, Colombia, Latin America And East Asia
Gliford 5 contains Glibenclamide IP 5 mg, a sulfonylurea antidiabetic medication indicated for the management of Type 2 Diabetes Mellitus. It helps lower blood glucose levels by stimulating insulin secretion from the pancreas, supporting effective glycemic control when used alongside a healthy diet and regular exercise.
|
Contain |
Glibenclamide IP 5 Mg |
|---|---|
|
Strength |
5 Mg |
|
Packaging |
20X10TAB |
|
Category |
Categories: Diabetic Care |
|
Manufacturer |
Johnlee Pharmaceuticals Pvt. Ltd |
|
Brand |
Gliford |
Product Overview
Gliford 5 contains Glibenclamide, a second-generation sulfonylurea oral antidiabetic medication widely used for the treatment of Type 2 Diabetes Mellitus. It is prescribed to improve blood glucose control in adults whose diabetes cannot be adequately managed through diet, exercise, and lifestyle modifications alone. With its established clinical efficacy and long-standing use, Glibenclamide remains an important therapeutic option in modern diabetes management.
Gliford 5 works by stimulating the pancreas to release insulin, helping the body regulate blood glucose levels more effectively. It is commonly prescribed as monotherapy or in combination with other oral antidiabetic agents or insulin, depending on the patient’s clinical needs and treatment goals. By maintaining better glycemic control, Gliford 5 helps reduce the risk of long-term diabetes-related complications and supports overall metabolic health.
Manufactured under stringent pharmaceutical quality standards, Gliford 5 provides consistent efficacy, safety, and reliability, making it a trusted choice for healthcare professionals in the management of Type 2 Diabetes Mellitus.
How It Works
Glibenclamide stimulates the beta cells of the pancreas to increase insulin secretion, helping lower blood glucose levels. By improving the body’s natural insulin response, it promotes efficient glucose utilization and contributes to maintaining stable blood sugar levels throughout the day.
Therapeutic Applications
Gliford 5 may be prescribed for the management of:
- Type 2 Diabetes Mellitus
- Blood Glucose Control
- Long-Term Glycemic Management
- Combination Therapy with other Antidiabetic Medications
- Patients inadequately controlled by diet and exercise alone
Key Benefits
- Effectively lowers blood glucose levels.
- Stimulates natural insulin secretion from the pancreas.
- Supports long-term glycemic control.
- Can be used alone or in combination with other antidiabetic therapies.
- Convenient oral tablet for daily diabetes management.
- Manufactured under stringent pharmaceutical quality standards.
Quality Commitment
Vinix Biopharma is committed to delivering high-quality antidiabetic medicines manufactured in accordance with stringent pharmaceutical quality standards. Gliford 5 undergoes comprehensive quality assurance and rigorous testing to ensure safety, efficacy, consistency, and reliability. Every batch is carefully evaluated to maintain product integrity and support optimal patient care.
Storage Information
Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.
Disclaimer
Gliford 5 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the patient’s clinical condition, medical history, and therapeutic requirements.




